戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 uch as Alzheimer disease, hydrocephalus, and pseudotumor cerebri.
2 se, urinary incontinence, venous stasis, and pseudotumor cerebri.
3 eroid treatment; these can be referred to as pseudotumor cerebri.
4 ), (2) idiopathic intracranial hypertension (pseudotumor cerebri), (3) nonarteritic anterior ischemic
5                                              Pseudotumor cerebri also occurred at 600 mg/m2 and 800 m
6                                              Pseudotumor cerebri (also called idiopathic intracranial
7 ent role of imaging techniques in diagnosing pseudotumor cerebri and describe and illustrate the most
8 t have been evaluated for diagnosing primary pseudotumor cerebri and predicting the response to treat
9  disease symptoms, type 2 diabetes mellitus, pseudotumor cerebri, and urinary incontinence.
10 interventional radiology in the treatment of pseudotumor cerebri because placing a stent in stenosed
11 ior reversible leukoencephalopathy syndrome, pseudotumor cerebri, disturbances in eye movements, acco
12 ic intracranial hypertension), and secondary pseudotumor cerebri, in which the cause can be identifie
13 paper aims to define the concepts of primary pseudotumor cerebri, in which the cause cannot be identi
14                                              Pseudotumor cerebri is a disorder characterized by incre
15 is/multiple sclerosis, neuromyelitis optica, pseudotumor cerebri, migraine, optic nerve head drusen,
16 , grade 4 bilirubin/grade 3 AST/ALT (n = 1), pseudotumor cerebri (n = 1).
17                                              Pseudotumor cerebri or dose-limiting headache was observ
18 optic neuropathies, the ocular motor system, pseudotumor cerebri, posterior reversible encephalopathy
19                                              Pseudotumor cerebri (PTC) is a syndrome defined by four
20 rrent standard in diagnosis and treatment of pseudotumor cerebri (PTC), the syndrome of increased int
21 en clinical features of tetracycline-induced pseudotumor cerebri (PTC-T) and those of idiopathic intr
22 her primary idiopathic (n = 59) or secondary pseudotumor cerebri syndrome (n = 16), as rigorously def
23          We reviewed patients diagnosed with pseudotumor cerebri syndrome (PTCS) at our center and id
24                                    Pediatric pseudotumor cerebri syndrome (PTCS) is a rare but signif
25 ociations observed in the possible secondary pseudotumor cerebri syndrome group included Down syndrom
26 ons and exposures seen in definite secondary pseudotumor cerebri syndrome included tetracycline-class
27 dotumor cerebri syndrome, definite secondary pseudotumor cerebri syndrome patients were on average ol
28 s seen at a tertiary children's hospital for pseudotumor cerebri syndrome were classified as having e
29 ssifications, 79% of children with secondary pseudotumor cerebri syndrome were either overweight or o
30                   In comparison with primary pseudotumor cerebri syndrome, definite secondary pseudot
31 nciting exposure is identified for pediatric pseudotumor cerebri syndrome, the possible contribution
32 to treat proliferative diabetic retinopathy, pseudotumor cerebri, thyroid orbitopathy, and cystoid ma